Imatron subsidiary HeartScan spending $2.3 mil. on radio ad campaign for CT-based cardiac risk service.
This article was originally published in The Gray Sheet
Executive Summary
HEARTSCAN'S $2-3 MIL. RADIO AD CAMPAIGN FOR CT-BASED CARDIAC RISK SERVICE should help the firm's Washington D.C. and Houston-based computed tomography diagnostic imaging centers turn a profit by mid-1998, HeartScan Imaging claims. The Imatron subsidiary adds that a third, San Francisco-based center also will "approach" profitability in 1998.
You may also be interested in...
ACC/AHA EBT Findings Based On Inappropriate Comparison - Imatron, SAI
Imatron Inc. is critical of research methods the American College of Cardiology and the American Heart Association used to compile an expert consensus document concluding that electron beam computed tomography demonstrates roughly 70% accuracy in predicting cardiac conditions in symptomatic patients.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.